1800-272-662
Shopping Cart 0
countryflagAU
Login

BlackRock Health Sciences Trust II

US BMEZ

14.48USD
-(-%)

Last update at 2026-03-11T20:00:00Z

Day Range

14.4314.61
LowHigh

52 Week Range

12.7615.86
LowHigh

Fundamentals

  • Previous Close 14.48
  • Market Cap1589.12M
  • Volume192855
  • P/E Ratio27.24
  • Dividend Yield8.10%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM0.54

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2020-12-31 2019-12-31
Type yearly yearly
Date 2020-12-31 2019-12-31
Income before tax 1485.00M 113.23M
Minority interest - -
Net income 1485.00M 113.23M
Selling general administrative 1.50M 0.48M
Selling and marketing expenses - -
Gross profit - -
Reconciled depreciation - -
Ebit - -
Ebitda 1485.00M 113.23M
Depreciation and amortization - -
Non operating income net other - -
Operating income - -
Other operating expenses - -
Interest expense 0.00000M 0.00000M
Tax provision - -
Interest income - 0.00000M
Net interest income - 0.00000M
Extraordinary items - -
Non recurring - -
Other items - -
Income tax expense - -
Total revenue 1486.87M 113.72M
Total operating expenses 1.87M 0.49M
Cost of revenue - -
Total other income expense net - -
Discontinued operations - -
Net income from continuing ops 1485.00M 113.23M
Net income applicable to common shares - -
Preferred stock and other adjustments - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets - - 3087.75M 1729.46M
Intangible assets - - - -
Earning assets - - - -
Other current assets - - - -
Total liab - - 64.01M 93.49M
Total stockholder equity - - 3023.74M 1635.97M
Deferred long term liab - - - -
Other current liab - - -1.75952M -1.52068M
Common stock - - 1506.84M 1518.69M
Capital stock - - - -
Retained earnings - - 1516.90M 117.28M
Other liab - - - -
Good will - - - -
Other assets - - 19.40M 8.75M
Cash - - 0.03M 0.50M
Cash and equivalents - - - -
Total current liabilities - - 1.76M 1.52M
Current deferred revenue - - - -
Net debt - - -0.03369M -0.50131M
Short term debt - - - -
Short long term debt - - - -
Short long term debt total - - - -
Other stockholder equity - - - -
Property plant equipment - - - -
Total current assets - - 0.41M 1.08M
Long term investments - - 3067.94M 1719.63M
Net tangible assets - - - -
Short term investments - - - -
Net receivables - - 0.38M 0.57M
Long term debt - - - -
Inventory - - - -
Accounts payable - - 1.76M 1.52M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - 1506.84M 1518.69M
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - -3067.94151M -1719.63133M
Deferred long term asset charges - - - -
Non current assets total - - 3067.94M 1719.63M
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2020-12-31 2019-12-31
Type yearly yearly
Date 2020-12-31 2019-12-31
Investments - -
Change to liabilities - -
Total cashflows from investing activities - -
Net borrowings - -
Total cash from financing activities -96.98316M 1524.16M
Change to operating activities - -
Net income 1485.00M 113.23M
Change in cash 10.18M 9.15M
Begin period cash flow 9.25M 0.10M
End period cash flow 19.44M 9.25M
Total cash from operating activities 107.17M -1515.00494M
Issuance of capital stock - -
Depreciation - -
Other cashflows from investing activities - -
Dividends paid -96.98316M -33.34175M
Change to inventory - -
Change to account receivables - -
Sale purchase of stock - 0.00000M
Other cashflows from financing activities - 1557.50M
Change to netincome - -
Capital expenditures 0.00000M 0.00000M
Change receivables - -
Cash flows other operating - -
Exchange rate changes - -
Cash and cash equivalents changes - -
Change in working capital -66.75756M 70.10M
Stock based compensation - -
Other non cash items -1311.07595M -1698.33710M
Free cash flow 107.17M -1515.00494M

Peer Comparison

Sector: Industry:

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
BMEZ
BlackRock Health Sciences Trust II		 - -% 14.48 27.24 - 7.94 0.76 9.42
NCRRP
NCR Corp Pref A		 - -% 1075.00 1034.35 - - -
TBB
AT&T Inc		 -0.05 0.22% 22.20 4.60 - - -
STMZF
Scottish Mortgage Investment Trust PLC		 - -% 15.50 - - 2.56 -
SHZHY
Shenzhou International Group Holdings Limited		 -0.11 1.48% 7.31 24.80 14.99 0.63 3.21 0.51 1.99

Reports Covered

Stock Research & News

View All

Key Executives

Name Title Year Born
Mr. Jeffrey Gene Lee Portfolio Mang. NA
Dr. Xiang Liu Ph.D. Portfolio Mang. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.